FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2069926873> ?p ?o ?g. }

• W2069926873 endingPage "1298" @default.
• W2069926873 startingPage "1287" @default.
• W2069926873 abstract "Despite extensive characterization of the role of the EWS-ETS fusions, little is known about secondary genetic alterations and their clinical contribution to Ewing sarcoma (ES). It has been demonstrated that the molecular structure of EWS-ETS lacks prognostic value. Moreover, CDKN2A deletion and TP53 mutation, despite carrying a poor prognosis, are infrequent. In this scenario identifying secondary genetic alterations with a significant prevalence could contribute to understand the molecular mechanisms underlying the most aggressive forms of ES. We screened a 67 ES tumor set for copy number alterations by array comparative genomic hybridization. 1q gain (1qG), detected in 31% of tumor samples, was found markedly associated with relapse and poor overall and disease-free survival and demonstrated a prognostic value independent of classical clinical parameters. Reanalysis of an expression dataset belonging to an independent tumor set (n=37) not only validated this finding but also led us to identify a transcriptomic profile of severe cell cycle deregulation in 1qG ES tumors. Consistently, a higher proliferation rate was detected in this tumor subset by Ki-67 immunohistochemistry. CDT2, a 1q-located candidate gene encoding a protein involved in ubiquitin ligase activity and significantly overexpressed in 1qG ES tumors, was validated in vitro and in vivo proving its major contribution to this molecular and clinical phenotype. This integrative genomic study of 105 ES tumors in overall renders the potential value of 1qG and CDT2 overexpression as prognostic biomarkers and also affords a rationale for the application of already available new therapeutic compounds selectively targeting the protein-ubiquitin machinery." @default.
• W2069926873 created "2016-06-24" @default.
• W2069926873 creator A5003014435 @default.
• W2069926873 creator A5010454411 @default.
• W2069926873 creator A5015197719 @default.
• W2069926873 creator A5015636061 @default.
• W2069926873 creator A5019040135 @default.
• W2069926873 creator A5020658166 @default.
• W2069926873 creator A5022969007 @default.
• W2069926873 creator A5027922544 @default.
• W2069926873 creator A5044250695 @default.
• W2069926873 creator A5045183692 @default.
• W2069926873 creator A5052609273 @default.
• W2069926873 creator A5068651198 @default.
• W2069926873 creator A5074366700 @default.
• W2069926873 creator A5082527074 @default.
• W2069926873 creator A5083948167 @default.
• W2069926873 creator A5085470464 @default.
• W2069926873 creator A5086102127 @default.
• W2069926873 date "2011-08-08" @default.
• W2069926873 modified "2023-10-17" @default.
• W2069926873 title "1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma" @default.
• W2069926873 cites W1539814399 @default.
• W2069926873 cites W192341775 @default.
• W2069926873 cites W1974370722 @default.
• W2069926873 cites W1976133851 @default.
• W2069926873 cites W1985338503 @default.
• W2069926873 cites W1989149017 @default.
• W2069926873 cites W1995461329 @default.
• W2069926873 cites W1999748111 @default.
• W2069926873 cites W2000061217 @default.
• W2069926873 cites W2002275414 @default.
• W2069926873 cites W2006420081 @default.
• W2069926873 cites W2006790234 @default.
• W2069926873 cites W2007403856 @default.
• W2069926873 cites W2008223404 @default.
• W2069926873 cites W2018683213 @default.
• W2069926873 cites W2022352188 @default.
• W2069926873 cites W2023668959 @default.
• W2069926873 cites W2026853588 @default.
• W2069926873 cites W2029620675 @default.
• W2069926873 cites W2030988924 @default.
• W2069926873 cites W2032735361 @default.
• W2069926873 cites W2038673291 @default.
• W2069926873 cites W2047662812 @default.
• W2069926873 cites W2063602321 @default.
• W2069926873 cites W2065005324 @default.
• W2069926873 cites W2067708781 @default.
• W2069926873 cites W2068784898 @default.
• W2069926873 cites W2069351898 @default.
• W2069926873 cites W2075302847 @default.
• W2069926873 cites W2076194625 @default.
• W2069926873 cites W2096020932 @default.
• W2069926873 cites W2096116342 @default.
• W2069926873 cites W2108048969 @default.
• W2069926873 cites W2112156135 @default.
• W2069926873 cites W2112538093 @default.
• W2069926873 cites W2113126688 @default.
• W2069926873 cites W2130410032 @default.
• W2069926873 cites W2136182072 @default.
• W2069926873 cites W2139326294 @default.
• W2069926873 cites W2141419938 @default.
• W2069926873 cites W2161618888 @default.
• W2069926873 cites W2162611692 @default.
• W2069926873 cites W2164929415 @default.
• W2069926873 cites W2168027329 @default.
• W2069926873 cites W4248673725 @default.
• W2069926873 doi "https://doi.org/10.1038/onc.2011.317" @default.
• W2069926873 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21822310" @default.
• W2069926873 hasPublicationYear "2011" @default.
• W2069926873 type Work @default.
• W2069926873 sameAs 2069926873 @default.
• W2069926873 citedByCount "86" @default.
• W2069926873 countsByYear W20699268732012 @default.
• W2069926873 countsByYear W20699268732013 @default.
• W2069926873 countsByYear W20699268732014 @default.
• W2069926873 countsByYear W20699268732015 @default.
• W2069926873 countsByYear W20699268732016 @default.
• W2069926873 countsByYear W20699268732017 @default.
• W2069926873 countsByYear W20699268732018 @default.
• W2069926873 countsByYear W20699268732019 @default.
• W2069926873 countsByYear W20699268732020 @default.
• W2069926873 countsByYear W20699268732021 @default.
• W2069926873 countsByYear W20699268732022 @default.
• W2069926873 countsByYear W20699268732023 @default.
• W2069926873 crossrefType "journal-article" @default.
• W2069926873 hasAuthorship W2069926873A5003014435 @default.
• W2069926873 hasAuthorship W2069926873A5010454411 @default.
• W2069926873 hasAuthorship W2069926873A5015197719 @default.
• W2069926873 hasAuthorship W2069926873A5015636061 @default.
• W2069926873 hasAuthorship W2069926873A5019040135 @default.
• W2069926873 hasAuthorship W2069926873A5020658166 @default.
• W2069926873 hasAuthorship W2069926873A5022969007 @default.
• W2069926873 hasAuthorship W2069926873A5027922544 @default.
• W2069926873 hasAuthorship W2069926873A5044250695 @default.
• W2069926873 hasAuthorship W2069926873A5045183692 @default.
• W2069926873 hasAuthorship W2069926873A5052609273 @default.
• W2069926873 hasAuthorship W2069926873A5068651198 @default.

• next